Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.
about
Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteinsIL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.Interferon-gamma-responsive nonhematopoietic cells regulate the immune response to Mycobacterium tuberculosisTh17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa.Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways.Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice.Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidatesInfluenza A inhibits Th17-mediated host defense against bacterial pneumonia in miceComparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease.Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in mice.Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infectionsNeutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infectionInfluence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology.Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensisTh17 cells in human disease.Interleukin-12 and tuberculosis: an old story revisitedIL23R(Arg381Gln) functional polymorphism is associated with active pulmonary tuberculosis severity.Helper T cell differentiation enters a new era: le roi est mort; vive le roi!Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen.Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.Generation of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling.Interleukin-17 as an effector molecule of innate and acquired immunity against infections.IL-23 and IL-17 in tuberculosis.Pure insulin nanoparticle agglomerates for pulmonary delivery.Regulation and function of proinflammatory TH17 cells.Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens.The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis.Tuberculosis vaccines: present and future.Cytokine therapy of tuberculosis at the crossroads.Th17 cell dynamics in HIV infection.Mycobacterium Tuberculosis Infection and Inflammation: what is Beneficial for the Host and for the Bacterium?IL-17 in human asthma.Does p40-targeted therapy represent a significant evolution in the management of plaque psoriasis?Role of interleukin-23-dependent antifungal immune responses in dendritic cell-vaccinated miceCytokines and Chemokines in Mycobacterium tuberculosis Infection.Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-γ and interleukin-10.The Role of Neutrophils in the Induction of Specific Th1 and Th17 during Vaccination against Tuberculosis.Fasciola hepatica infection reduces Mycobacterium bovis burden and mycobacterial uptake and suppresses the pro-inflammatory response.
P2860
Q30371205-5A8D7F02-D529-4832-BAFF-8F850040ECE8Q30438358-70A50E61-736F-4631-8953-9D21BEC4278DQ33582232-D1FAE1C8-C06E-442D-BAB4-B4533D00AFBBQ33596687-E872F727-CE1E-44BF-A395-0C0359AFF7BEQ33611067-F181D8C1-3155-4127-B74A-B4F6CB49050AQ33642445-9927E9F9-0402-4CC5-8DD5-78004725F69AQ33908912-E5B37E78-84DF-4FE2-8590-2D7A71B195C2Q34484151-0A6B800F-AB1B-460B-92F6-40BC528306CBQ34647668-09382783-19E1-4B3A-9C8F-A314EE2B501FQ34764015-D1CE9663-C4B1-4C65-840F-36CF78419C06Q34807329-2791AB56-FE53-4CAF-B6A3-5DCCE5297D8AQ34983663-6709C73A-37A6-4987-8374-E5CB509728DCQ35205539-ABE015C2-B4C2-432E-A3EC-B9CCB75894AAQ35217462-3F2284F0-5879-4A04-BC1A-0E61738F4FA8Q35643199-569FEB1D-02FA-4B9C-B83F-6C8E8EA43853Q35689466-197E704E-52AF-4947-9933-7EA7250EAF0EQ35820734-BD6874E4-81FE-47A6-B6B9-C953B70C5478Q36137298-6DD7A771-589D-4EA5-8595-138C93E23F0BQ36154702-A9841D29-B825-4212-8698-B6656376BDCCQ36228555-E8596C7A-17F7-4B11-B96B-4B1A507B0DB9Q36421582-E68B0F44-D814-4872-8903-C0514940AD0FQ36710729-FEE80AAE-0920-47D4-950C-F34E981902C6Q36944487-BD4751CD-2F0C-4DFD-89DD-728DCE6B5BDDQ37038277-CDBC7DC2-1261-451B-8181-C271FF3712EFQ37064619-82DD8D92-86D1-45B0-91C8-6F560D0856D0Q37113482-2E63C81B-3CE7-42DE-8B34-E41DCD090669Q37348457-BBFC9594-4216-4475-B7A8-4F7ACF55C593Q37363266-9CBACC01-46CB-4726-A9AC-81E9563CBF0DQ37374958-23267570-8B6E-4F8B-B7AC-9E718A00C026Q37754908-F8DDAD1A-96B7-4A2A-8B52-51869A5FE7A8Q37754962-28C69C84-EA73-49FC-AB82-53B570297DC0Q37764649-A111C71D-2F5C-4112-9AB8-792DE7103E3EQ37891772-2AF9B411-3822-4E13-9DF6-B4621BDD1945Q37997818-E91FF399-4968-4F88-AA4F-790E6AC19BD8Q38023581-438AA5B8-BED7-4E5F-B495-556564C5507FQ38283980-EE644787-CDA4-42F8-866E-F2ACD4FB1D4AQ38986062-AD7B32F4-7805-440B-96AF-287B77044B37Q39290449-02495E0A-9B77-4B3D-9A10-DB6ECDC5A4C1Q39533192-8797AC11-A397-45CE-BE70-C339B5AEDE78Q40701526-5FDA30ED-4B1C-4F9A-A882-5C3DF12CB24D
P2860
Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@ast
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@en
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@nl
type
label
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@ast
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@en
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@nl
prefLabel
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@ast
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@en
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@nl
P2093
P2860
P1476
Pulmonary interleukin-23 gene ...... ium tuberculosis in the lungs.
@en
P2093
Alistair J Ramsay
Anthony R Odden
Carol M Mason
Elizabeth Keoshkerian
Elizabeth Porretta
Euan A Lockhart
Kyle I Happel
Steve Nelson
P2860
P304
P356
10.1128/IAI.73.9.5782-5788.2005
P407
P577
2005-09-01T00:00:00Z